
AI is changing drug safety, but governance sets the guardrails (Sponsored)
Artificial intelligence is reshaping drug safety, but governance is just as critical as innovation, according to Marie Flanagan of IQVIA Safety Technologies. Speaking on The Top Line podcast, Flanagan said responsibility for AI in healthcare must be shared across compliance, technology, business teams and regulators. Strong governance, she said, ensures AI systems are ethically designed, technically validated, transparent and adaptable to continuous oversight.
Organizations can prepare by grounding their strategies in guiding principles such as human oversight, fairness and accountability…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.